VRBCF
Virbac SA
Price Chart
Latest Quote
$408.00
+0.00 (+0.00%)
Current Price
| Previous Close | $408.00 |
| Open | $431.80 |
| Day High | $431.80 |
| Day Low | $431.80 |
| Volume | 1 |
Stock Information
Note: Financial values converted from EUR to USD
| Quarterly Dividend / Yield | $1.69 / 0.42% |
| Shares Outstanding | 8.38M |
| Quarterly Dividend Yield | 0.42% |
| Quarterly Dividend | $1.69 |
| Total Debt | $337.18M |
| Cash Equivalents | $146.87M |
| Revenue | $1.71B |
| Net Income | $175.65M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Market Cap | $3.42B |
| P/E Ratio | 19.49 |
| EPS (TTM) | $20.93 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $3.58B |
| Sales | $1.71B |
| Income | $175.65M |
| Book/sh | $146.18 |
| Cash/sh | $15.05 |
| Employees | 6K |
Financial Ratios
| Quick Ratio | 0.77 |
| Current Ratio | 1.53 |
| Debt/Eq | 25.75 |
| EPS Growth TTM | 35.30% |
Returns & Margins
| ROA | 7.65% |
| ROE | 13.88% |
| Gross Margin | 66.69% |
| Operating Margin | 13.47% |
| Profit Margin | 10.30% |
Ownership
| Insider Ownership | 50.82% |
| Institutional Ownership | 25.24% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 2.33 |
| P/B | 2.79 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $403.35 |
| SMA50 | $392.19 |
| SMA200 | $357.74 |
| RSI | nan |
| Shares Float | 4.13M |
| Volatility | 0.77 |
Performance History
| Week | +0.00% |
| Month | +6.04% |
| Quarter | +17.92% |
| 6 Months | +17.92% |
| YTD | +17.92% |
| Year | +18.42% |
| 3 Years | +3.14% |
| 5 Years | +29.12% |
| 10 Years | +129.17% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-03 | $408.00 | 0 |
| 2026-06-02 | $408.00 | 0 |
| 2026-06-01 | $408.00 | 0 |
| 2026-05-29 | $408.00 | 0 |
| 2026-05-28 | $408.00 | 0 |
| 2026-05-27 | $408.00 | 0 |
| 2026-05-26 | $408.00 | 0 |
| 2026-05-22 | $408.00 | 0 |
| 2026-05-21 | $408.00 | 0 |
| 2026-05-20 | $408.00 | 0 |
| 2026-05-19 | $408.00 | 0 |
| 2026-05-18 | $408.00 | 0 |
| 2026-05-15 | $408.00 | 0 |
| 2026-05-14 | $408.00 | 0 |
| 2026-05-13 | $408.00 | 0 |
| 2026-05-12 | $408.00 | 64 |
| 2026-05-11 | $384.75 | 0 |
| 2026-05-08 | $384.75 | 0 |
| 2026-05-07 | $384.75 | 0 |
| 2026-05-06 | $384.75 | 0 |
| 2026-05-05 | $384.75 | 0 |
| 2026-05-04 | $384.75 | 0 |
About Virbac SA
Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific. The company offers Vikaly, a cat food designed for the management of feline chronic kidney disease; Prevexto that contains imidacloprid and flumethrin, providing long-lasting parasite protection collar for dogs and cats at risk of fleas, ticks, lice, and sandflies; Zenidog/Zenifel offers a fogger, spray, and non-electric pheromone gel diffuser to soothe and reduce stress-related behaviors in dogs; Suigen Entero 3 is an inactivated vaccine aimed at preventing neonatal diarrhea in piglets caused by colibacillosis, clostridium, and rotavirus; Ursolyx soft chews formulated with ursolic acid that support muscle strength and mobility in dogs and cats; Zenifel a fogger and spray designed to reduce behaviors due to stress or undesirable behaviors in cats; Suigen PCV2 is a vaccine for porcine circovirus type 2; and Suigen Donoban is a multivalent vaccine used for the prevention of respiratory diseases in swine. It also provides a range of vaccines, antibiotics, parasiticides, and anti-inflammatory drugs, as well as dermatology, dental, specialty, diagnosis, immunology, nutrition, petfood, and pharmaceutical products. In addition, the company serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
đ° Latest News
A Look At Virbac (ENXTPA:VIRP) Valuation As Shares Ease Despite Longer Term Gains
Simply Wall St. âĸ 2026-05-04T22:11:10Z
Virbac shares jump on Q1 growth as North America surge offsets FX drag
Investing.com âĸ 2026-04-17T08:07:32ZAssessing Virbac (ENXTPA:VIRP) Valuation As Investors Revisit The Stockâs Recent Performance
Simply Wall St. âĸ 2026-03-18T20:05:43Z
Is Virbac (ENXTPA:VIRP) Offering Value After Strong Multi Year Share Price Gains
Simply Wall St. âĸ 2026-01-14T02:10:37Z
How Analyst Optimism Is Changing the Growth Story for Virbac
Simply Wall St. âĸ 2025-11-08T20:13:51Z
GL Events Valuation in Focus After Strong 61.7% Year-to-Date Rally
Simply Wall St. âĸ 2025-09-09T12:54:33Z
Evaluating Virbacâs Future After Recent 9.3% Decline and Market Volatility in 2025
Simply Wall St. âĸ 2025-09-09T12:44:46Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $459,776,000 | $437,303,000 | $426,221,000 | $363,093,000 |
| Cost Of Revenue | $459,776,000 | $437,303,000 | $426,221,000 | $363,093,000 |
| Total Revenue | $1,397,379,000 | $1,246,901,000 | $1,216,187,000 | $1,063,966,000 |
| Operating Revenue | $1,397,379,000 | $1,246,901,000 | $1,216,187,000 | $1,063,966,000 |
| Expenses | ||||
| Interest Expense | $11,119,000 | $8,882,000 | $3,691,000 | $5,982,000 |
| Total Expenses | $1,169,072,000 | $1,061,198,000 | $1,032,715,000 | $897,200,000 |
| Net Non Operating Interest Income Expense | $-4,308,000 | $256,000 | $1,000,000 | $-3,793,000 |
| Total Other Finance Cost | $-419,000 | $-414,000 | $140,000 | $180,000 |
| Interest Expense Non Operating | $11,119,000 | $8,882,000 | $3,691,000 | $5,982,000 |
| Operating Expense | $709,296,000 | $623,895,000 | $606,494,000 | $534,107,000 |
| Other Operating Expenses | $280,325,000 | $247,647,000 | $250,752,000 | $208,774,000 |
| Other Non Operating Income Expenses | - | - | $1,625,000 | $1,912,000 |
| General And Administrative Expense | - | - | - | $203,465,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $145,290,000 | $121,298,000 | $121,943,000 | $113,162,000 |
| Net Interest Income | $-4,308,000 | $256,000 | $1,000,000 | $-3,793,000 |
| Interest Income | $6,392,000 | $8,724,000 | $4,831,000 | $2,369,000 |
| Normalized Income | $155,347,964 | $118,397,511 | $127,167,941 | $119,413,757 |
| Net Income From Continuing And Discontinued Operation | $145,290,000 | $121,298,000 | $121,943,000 | $113,162,000 |
| Total Operating Income As Reported | $227,497,000 | $184,876,000 | $182,816,000 | $167,626,000 |
| Net Income Common Stockholders | $145,290,000 | $121,298,000 | $121,943,000 | $113,162,000 |
| Net Income | $145,290,000 | $121,298,000 | $121,943,000 | $113,162,000 |
| Net Income Including Noncontrolling Interests | $145,782,000 | $121,088,000 | $121,295,000 | $115,691,000 |
| Net Income Continuous Operations | $145,782,000 | $121,088,000 | $121,295,000 | $115,691,000 |
| Pretax Income | $207,793,000 | $174,153,000 | $176,443,000 | $159,107,000 |
| Special Income Charges | $-11,230,000 | $-1,705,000 | $-3,953,000 | $-1,051,000 |
| Interest Income Non Operating | $6,392,000 | $8,724,000 | $4,831,000 | $2,369,000 |
| Operating Income | $228,307,000 | $185,703,000 | $183,472,000 | $166,766,000 |
| Depreciation And Amortization In Income Statement | $57,236,000 | $47,519,000 | $45,816,000 | $43,344,000 |
| Depreciation Income Statement | $45,226,000 | $37,880,000 | $36,030,000 | $33,751,000 |
| Gross Profit | $937,603,000 | $809,598,000 | $789,966,000 | $700,873,000 |
| Per Share | ||||
| Diluted EPS | $17.34 | $14.38 | $14.42 | $13.38 |
| Basic EPS | $17.35 | $14.40 | $14.43 | $13.40 |
| Other | ||||
| Tax Effect Of Unusual Items | $-3,439,036 | $1,081,511 | $-2,132,059 | $-2,277,243 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $289,761,000 | $226,671,000 | $236,557,000 | $216,962,000 |
| Total Unusual Items | $-13,497,000 | $3,982,000 | $-7,357,000 | $-8,529,000 |
| Total Unusual Items Excluding Goodwill | $-13,497,000 | $3,982,000 | $-7,357,000 | $-8,529,000 |
| Reconciled Depreciation | $57,352,000 | $47,618,000 | $49,066,000 | $38,909,000 |
| EBITDA (Bullshit earnings) | $276,264,000 | $230,653,000 | $229,200,000 | $208,433,000 |
| EBIT | $218,912,000 | $183,035,000 | $180,134,000 | $165,089,000 |
| Diluted Average Shares | $8,379,307 | $8,437,213 | $8,454,274 | $8,458,000 |
| Basic Average Shares | $8,372,978 | $8,421,787 | $8,448,180 | $8,442,111 |
| Diluted NI Availto Com Stockholders | $145,290,000 | $121,298,000 | $121,943,000 | $113,162,000 |
| Otherunder Preferred Stock Dividend | $0 | $0 | $0 | $0 |
| Minority Interests | $-492,000 | $210,000 | $648,000 | $-2,529,000 |
| Tax Provision | $62,478,000 | $53,520,000 | $55,673,000 | $43,612,000 |
| Other Special Charges | $2,826,000 | $2,858,000 | $473,000 | $3,051,000 |
| Write Off | $-719,000 | $-389,000 | $-212,000 | $-342,000 |
| Impairment Of Capital Assets | $-860,000 | $-836,000 | $3,692,000 | $-1,658,000 |
| Restructuring And Mergern Acquisition | $9,983,000 | $72,000 | - | - |
| Amortization | $12,010,000 | $9,639,000 | $9,786,000 | $9,593,000 |
| Selling General And Administration | - | - | - | $203,465,000 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $515,248,000 | $549,822,000 | $540,131,000 | $435,659,000 |
| Total Assets | $1,848,522,000 | $1,455,730,000 | $1,333,620,000 | $1,201,551,000 |
| Total Non Current Assets | $1,004,401,000 | $684,246,000 | $610,093,000 | $576,882,000 |
| Other Non Current Assets | $4,000 | $3,000 | $-1,000 | $2,000 |
| Non Current Deferred Taxes Assets | $24,628,000 | $22,323,000 | $24,668,000 | $22,006,000 |
| Financial Assets | $1,384,000 | $43,000 | $89,000 | $137,000 |
| Investmentin Financial Assets | $342,000 | $325,000 | $319,000 | $225,000 |
| Goodwill And Other Intangible Assets | $527,869,000 | $350,479,000 | $299,508,000 | $289,276,000 |
| Other Intangible Assets | $251,236,000 | $185,107,000 | $154,398,000 | $148,749,000 |
| Current Assets | $844,119,000 | $771,484,000 | $723,527,000 | $624,668,000 |
| Hedging Assets Current | $4,274,000 | $2,495,000 | $2,488,000 | $1,779,000 |
| Assets Held For Sale Current | $0 | $0 | $0 | $0 |
| Restricted Cash | $0 | $0 | $0 | $0 |
| Prepaid Assets | $17,367,000 | $13,311,000 | $12,183,000 | $10,773,000 |
| Inventory | $404,166,000 | $339,663,000 | $330,909,000 | $270,332,000 |
| Other Receivables | $59,418,000 | $50,739,000 | $42,313,000 | $51,559,000 |
| Taxes Receivable | $13,183,000 | $21,392,000 | $11,961,000 | $10,072,000 |
| Accounts Receivable | $196,080,000 | $167,978,000 | $146,290,000 | $107,366,000 |
| Allowance For Doubtful Accounts Receivable | $-2,847,000 | $-2,822,000 | $-2,419,000 | $-2,248,000 |
| Gross Accounts Receivable | $198,927,000 | $170,800,000 | $148,709,000 | $109,614,000 |
| Cash Cash Equivalents And Short Term Investments | $149,631,000 | $175,906,000 | $177,383,000 | $172,787,000 |
| Cash And Cash Equivalents | $149,631,000 | $175,906,000 | $177,383,000 | $172,787,000 |
| Cash Equivalents | $44,685,000 | $96,611,000 | $110,118,000 | $107,670,000 |
| Cash Financial | $104,945,000 | $79,294,000 | $67,265,000 | $65,117,000 |
| Debt | ||||
| Net Debt | $119,281,000 | - | - | - |
| Total Debt | $307,014,000 | $120,110,000 | $90,395,000 | $94,466,000 |
| Long Term Debt And Capital Lease Obligation | $244,277,000 | $65,619,000 | $45,387,000 | $42,610,000 |
| Long Term Debt | $217,725,000 | $40,618,000 | $17,995,000 | $13,151,000 |
| Current Debt And Capital Lease Obligation | $62,737,000 | $54,491,000 | $45,008,000 | $51,856,000 |
| Current Debt | $51,187,000 | $44,347,000 | $35,593,000 | $42,861,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $805,119,000 | $545,813,000 | $494,332,000 | $476,360,000 |
| Total Non Current Liabilities Net Minority Interest | $340,559,000 | $146,765,000 | $103,746,000 | $105,609,000 |
| Other Non Current Liabilities | $-1,000 | $-2,000 | $-1,000 | $-1,000 |
| Derivative Product Liabilities | $0 | $0 | $0 | $797,000 |
| Tradeand Other Payables Non Current | $4,201,000 | $21,162,000 | $5,308,000 | $5,735,000 |
| Non Current Deferred Taxes Liabilities | $57,233,000 | $31,560,000 | $25,765,000 | $27,883,000 |
| Current Liabilities | $464,560,000 | $399,048,000 | $390,586,000 | $370,751,000 |
| Payables | $392,061,000 | $337,337,000 | $335,525,000 | $311,047,000 |
| Other Payable | $174,050,000 | $167,474,000 | $158,258,000 | $149,840,000 |
| Total Tax Payable | $43,437,000 | $20,234,000 | $21,447,000 | $33,605,000 |
| Accounts Payable | $174,574,000 | $149,629,000 | $155,820,000 | $127,602,000 |
| Equity | ||||
| Common Stock Equity | $1,043,117,000 | $900,301,000 | $839,639,000 | $724,935,000 |
| Total Equity Gross Minority Interest | $1,043,403,000 | $909,917,000 | $839,288,000 | $725,191,000 |
| Stockholders Equity | $1,043,117,000 | $900,301,000 | $839,639,000 | $724,935,000 |
| Retained Earnings | $145,290,000 | $121,298,000 | $121,943,000 | $113,162,000 |
| Long Term Equity Investment | $4,511,000 | $4,244,000 | $4,423,000 | $3,721,000 |
| Other Equity Interest | - | - | $-1,000 | - |
| Other | ||||
| Treasury Shares Number | $16,066 | $88,281 | $15,852 | $10,457 |
| Ordinary Shares Number | $8,374,594 | $8,369,719 | $8,442,148 | $8,447,543 |
| Share Issued | $8,390,660 | $8,458,000 | $8,458,000 | $8,458,000 |
| Tangible Book Value | $515,248,000 | $549,822,000 | $540,131,000 | $435,659,000 |
| Invested Capital | $1,312,029,000 | $985,266,000 | $893,227,000 | $780,947,000 |
| Working Capital | $379,559,000 | $372,436,000 | $332,941,000 | $253,917,000 |
| Capital Lease Obligations | $38,102,000 | $35,145,000 | $36,807,000 | $38,454,000 |
| Total Capitalization | $1,260,842,000 | $940,919,000 | $857,634,000 | $738,086,000 |
| Minority Interest | $286,000 | $9,616,000 | $-351,000 | $256,000 |
| Additional Paid In Capital | $6,534,000 | $6,534,000 | $6,534,000 | $6,534,000 |
| Capital Stock | $10,488,000 | $10,573,000 | $10,573,000 | $10,573,000 |
| Common Stock | $10,488,000 | $10,573,000 | $10,573,000 | $10,573,000 |
| Non Current Pension And Other Postretirement Benefit Plans | $20,375,000 | $19,627,000 | $18,608,000 | $21,076,000 |
| Non Current Deferred Revenue | $1,229,000 | $1,450,000 | $1,846,000 | $1,153,000 |
| Long Term Capital Lease Obligation | $26,552,000 | $25,001,000 | $27,392,000 | $29,459,000 |
| Long Term Provisions | $8,899,000 | $7,299,000 | $6,833,000 | $6,356,000 |
| Current Capital Lease Obligation | $11,550,000 | $10,144,000 | $9,415,000 | $8,995,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $929,000 | $1,135,000 | $1,076,000 | $894,000 |
| Current Provisions | $776,000 | $2,309,000 | $1,039,000 | $1,612,000 |
| Available For Sale Securities | $342,000 | $325,000 | $319,000 | $225,000 |
| Goodwill | $276,633,000 | $165,372,000 | $145,110,000 | $140,527,000 |
| Net PPE | $434,397,000 | $300,955,000 | $275,238,000 | $256,128,000 |
| Accumulated Depreciation | $-497,181,000 | $-349,637,000 | $-319,298,000 | $-287,256,000 |
| Gross PPE | $931,578,000 | $650,592,000 | $594,536,000 | $543,384,000 |
| Construction In Progress | $94,329,000 | $34,686,000 | $26,597,000 | $28,285,000 |
| Other Properties | $45,637,000 | $41,098,000 | $38,360,000 | $34,077,000 |
| Machinery Furniture Equipment | $371,588,000 | $286,580,000 | $264,569,000 | $235,558,000 |
| Buildings And Improvements | $367,303,000 | $260,993,000 | $246,668,000 | $227,572,000 |
| Land And Improvements | $52,721,000 | $27,235,000 | $18,342,000 | $17,892,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $265,268,000 | $210,458,000 | $203,459,000 | $172,321,000 |
| Work In Process | $23,376,000 | $27,771,000 | $24,786,000 | $15,007,000 |
| Raw Materials | $115,522,000 | $101,434,000 | $102,664,000 | $83,003,000 |
| Non Current Accrued Expenses | - | - | $0 | $0 |
| Other Inventories | - | - | $-1,000 | $1,000 |
| Investmentsin Associatesat Cost | - | - | - | $3,721,000 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $123,782,000 | $58,740,000 | $45,407,000 | $82,737,000 |
| Operating Activities | ||||
| Operating Cash Flow | $204,221,000 | $118,641,000 | $98,984,000 | $129,904,000 |
| Investing Activities | ||||
| Capital Expenditure | $-80,439,000 | $-59,901,000 | $-53,577,000 | $-47,167,000 |
| Investing Cash Flow | $-428,689,000 | $-121,869,000 | $-54,832,000 | $-51,214,000 |
| Net Other Investing Changes | - | $1,000 | - | $1,000 |
| Financing Activities | ||||
| Financing Cash Flow | $138,585,000 | $-2,723,000 | $-34,755,000 | $-91,693,000 |
| Net Other Financing Charges | $-17,492,000 | $13,000 | $1,140,000 | $-55,008,000 |
| Cash Dividends Paid | $-11,054,000 | $-11,165,000 | $-10,573,000 | $-6,343,000 |
| Common Stock Dividend Paid | $-11,054,000 | $-11,165,000 | $-10,573,000 | $-6,343,000 |
| Net Common Stock Issuance | $0 | $-19,422,000 | $-3,451,000 | $174,000 |
| Dividends Received Cfi | $463,000 | $475,000 | $0 | $0 |
| Other | ||||
| Repayment Of Debt | $-89,291,000 | $-50,492,000 | $-96,478,000 | $-77,984,000 |
| Issuance Of Debt | $273,632,000 | $88,651,000 | $85,439,000 | $65,643,000 |
| End Cash Position | $146,037,000 | $173,358,000 | $176,679,000 | $172,136,000 |
| Other Cash Adjustment Outside Changein Cash | $57,623,000 | $7,975,000 | $2,000 | $-1,000 |
| Beginning Cash Position | $173,358,000 | $176,679,000 | $172,136,000 | $179,567,000 |
| Effect Of Exchange Rate Changes | $939,000 | $-5,345,000 | $-4,856,000 | $5,573,000 |
| Changes In Cash | $-85,883,000 | $-5,951,000 | $9,397,000 | $-13,003,000 |
| Interest Paid Cff | $-4,727,000 | $-159,000 | - | $-3,612,000 |
| Net Issuance Payments Of Debt | $184,341,000 | $38,159,000 | $-11,039,000 | $-12,341,000 |
| Net Long Term Debt Issuance | $184,341,000 | $38,159,000 | $-11,039,000 | $-12,341,000 |
| Long Term Debt Payments | $-89,291,000 | $-50,492,000 | $-96,478,000 | $-77,984,000 |
| Long Term Debt Issuance | $273,632,000 | $88,651,000 | $85,439,000 | $65,643,000 |
| Net Investment Purchase And Sale | $2,934,000 | $645,000 | $-1,154,000 | $-3,157,000 |
| Net Business Purchase And Sale | $-348,436,000 | $-62,367,000 | $0 | $-5,908,000 |
| Sale Of Business | $0 | $0 | $0 | $0 |
| Purchase Of Business | $-348,436,000 | $-62,367,000 | $0 | $-5,908,000 |
| Net Intangibles Purchase And Sale | $-10,919,000 | $-18,656,000 | $-14,460,000 | $-10,608,000 |
| Sale Of Intangibles | $274,000 | $203,000 | $374,000 | $2,907,000 |
| Purchase Of Intangibles | $-11,193,000 | $-18,859,000 | $-14,834,000 | $-13,515,000 |
| Net PPE Purchase And Sale | $-69,246,000 | $-41,042,000 | $-38,743,000 | $-33,652,000 |
| Purchase Of PPE | $-69,246,000 | $-41,042,000 | $-38,743,000 | $-33,652,000 |
| Taxes Refund Paid | $22,619,000 | $-10,003,000 | $-13,712,000 | $-13,000 |
| Interest Received Cfo | $4,727,000 | $159,000 | $-1,140,000 | $3,612,000 |
| Change In Working Capital | $-29,178,000 | $-39,335,000 | $-54,790,000 | $-30,199,000 |
| Change In Other Current Assets | $-7,472,000 | $1,673,000 | $13,374,000 | $10,989,000 |
| Change In Payable | $4,076,000 | $-9,941,000 | $25,443,000 | $18,693,000 |
| Change In Inventory | $-20,890,000 | $-9,027,000 | $-55,771,000 | $-54,262,000 |
| Change In Receivables | $-4,892,000 | $-22,040,000 | $-37,836,000 | $-5,619,000 |
| Other Non Cash Items | $5,519,000 | $-4,090,000 | $4,092,000 | $8,152,000 |
| Deferred Tax | $-4,584,000 | $1,686,000 | $-5,739,000 | $-9,061,000 |
| Depreciation And Amortization | $57,352,000 | $47,618,000 | $49,066,000 | $38,909,000 |
| Depreciation | $57,352,000 | $47,618,000 | $49,066,000 | $38,909,000 |
| Gain Loss On Investment Securities | $2,451,000 | $1,973,000 | $439,000 | $3,009,000 |
| Net Income From Continuing Operations | $145,782,000 | $121,088,000 | $121,295,000 | $115,691,000 |
| Interest Paid Cfo | - | - | $-1,140,000 | - |
Fetched: 2026-02-02